Eurofins Scient (OTCMKTS:ERFSF) Given Average Rating of “Hold” by Brokerages

Shares of Eurofins Scient (OTCMKTS:ERFSF) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company.

A number of equities research analysts recently commented on ERFSF shares. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research report on Wednesday, October 22nd. BNP Paribas upgraded shares of Eurofins Scient to an “outperform” rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th.

Eurofins Scient Price Performance

Shares of ERFSF stock opened at $81.76 on Friday. Eurofins Scient has a fifty-two week low of $46.37 and a fifty-two week high of $83.02. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The stock’s 50-day simple moving average is $70.32 and its 200-day simple moving average is $72.96.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.